96 related articles for article (PubMed ID: 2163041)
1. Kappa-opioid agonist inhibits phospholipase C, possibly via an inhibition of G-protein activity.
Misawa H; Ueda H; Satoh M
Neurosci Lett; 1990 May; 112(2-3):324-7. PubMed ID: 2163041
[TBL] [Abstract][Full Text] [Related]
2. A subtype of opioid kappa-receptor is coupled to inhibition of Gi1-mediated phospholipase C activity in the guinea pig cerebellum.
Misawa H; Ueda H; Katada T; Ui M; Satoh M
FEBS Lett; 1995 Mar; 361(1):106-10. PubMed ID: 7890026
[TBL] [Abstract][Full Text] [Related]
3. Evidence for receptor-mediated inhibition of intrinsic activity of GTP-binding protein, Gi1 and Gi2, but not G0 in reconstitution experiments.
Ueda H; Uno S; Harada J; Kobayashi I; Katada T; Ui M; Satoh M
FEBS Lett; 1990 Jun; 266(1-2):178-82. PubMed ID: 2163886
[TBL] [Abstract][Full Text] [Related]
4. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
Ueda H; Misawa H; Fukushima N; Takagi H
Eur J Pharmacol; 1987 Jun; 138(1):129-32. PubMed ID: 3040426
[TBL] [Abstract][Full Text] [Related]
5. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes.
Frances B; Moisand C; Meunier JC
Eur J Pharmacol; 1985 Nov; 117(2):223-32. PubMed ID: 2866971
[TBL] [Abstract][Full Text] [Related]
6. The effects of dynorphin A (1-13) and U50, 488H on free intracellular calcium in guinea pig cerebellar synaptosomes.
Olson KG; Welch SP
Life Sci; 1991; 48(6):575-81. PubMed ID: 1671526
[TBL] [Abstract][Full Text] [Related]
7. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cholinergic neurotransmission in guinea-pig airways by opioids.
Belvisi MG; Stretton CD; Barnes PJ
Br J Pharmacol; 1990 May; 100(1):131-7. PubMed ID: 1695531
[TBL] [Abstract][Full Text] [Related]
9. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action.
Czlonkowski A; Millan MJ; Herz A
Eur J Pharmacol; 1987 Oct; 142(1):183-4. PubMed ID: 2826175
[No Abstract] [Full Text] [Related]
10. Relationship between kappa 1 opioid receptor binding and inhibition of adenylyl cyclase in guinea pig brain membranes.
Konkoy CS; Childers SR
Biochem Pharmacol; 1993 Jan; 45(1):207-16. PubMed ID: 8381004
[TBL] [Abstract][Full Text] [Related]
11. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
Ukai M; Kameyama T
Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
Pugsley MK; Penz WP; Walker MJ; Wong TM
Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
[TBL] [Abstract][Full Text] [Related]
13. The mu, kappa and delta properties of various opioid agonists.
Takemori AE; Ikeda M; Portoghese PS
Eur J Pharmacol; 1986 Apr; 123(3):357-61. PubMed ID: 3013652
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of carbachol-stimulated phosphoinositide turnover by U-50,488H in rat hippocampus--involvement of GTP-binding protein.
Periyasamy S; Hoss W
Eur J Pharmacol; 1991 Jun; 207(2):101-9. PubMed ID: 1652445
[TBL] [Abstract][Full Text] [Related]
15. Production of hypothermia in the guinea pig by a kappa-agonist opioid alone and in combination with chlorpromazine.
Adler MW; Bradley E; Martinez R; Geller EB
Pharmacol Biochem Behav; 1991 Sep; 40(1):129-32. PubMed ID: 1664107
[TBL] [Abstract][Full Text] [Related]
16. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
Yamamoto T; Ohno M; Ueki S
Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
[TBL] [Abstract][Full Text] [Related]
17. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
18. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
[TBL] [Abstract][Full Text] [Related]
19. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
Werling LL; McMahon PN; Cox BM
J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
